NFE2L2 and lung carcinoma: Aldo-keto-reductase 1C (AKR1C) family members were identified as NRF2-regulated ferroptosis-protective genes, and their increased expression underlies the progression of lung cancers with concurrent KEAP1 and STK11 mutations (Wohlhieter et al., 2020).